(Post-pandemic Era)-Global Subcutaneous Injector Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2023

Report ID: 271283 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Subcutaneous Injector Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Fillable -Product Introduction and Major Manufacturers
      1.1.2 Prefilled -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2020-2027)
    2.2 Regional Market Share in Terms of Revenue (2020-2027)
    2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Subcutaneous Injector Market Assessment by Type
    3.1 Global Subcutaneous Injector Production by Type (2016-2027)
    3.2 Global Subcutaneous Injector Revenue by Type (2016-2027)
    3.3 North America Subcutaneous Injector Production and Revenue by Type (2016-2027)
    3.4 Asia Subcutaneous Injector Production and Revenue by Type (2016-2027)
    3.5 Europe Subcutaneous Injector Production and Revenue by Type (2016-2027)
    3.6 Middle East & Africa Subcutaneous Injector Production and Revenue by Type (2016-2027)
    3.7 South America Subcutaneous Injector Production and Revenue by Type (2016-2027)

4 Global Subcutaneous Injector Market Assessment by Application
    4.1 Historical & Forecast Global Subcutaneous Injector Consumption, Different Application Field (2016-2027)
    4.2 Historical & Forecast North America Subcutaneous Injector Consumption, Different Application Field (2016-2027)
    4.3 Historical & Forecast Asia Subcutaneous Injector Consumption, Different Application Field (2016-2027)
    4.4 Historical & Forecast Europe Subcutaneous Injector Consumption, Different Application Field (2016-2027)
    4.5 Historical & Forecast Middle East & Africa Subcutaneous Injector Consumption, Different Application Field (2016-2027)
    4.6 Historical & Forecast South America Subcutaneous Injector Consumption, Different Application Field (2016-2027)

5 North America
    5.1 US Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.2 Canada Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.3 Mexico Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
    6.1 China Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.2 Japan Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.3 India Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.4 Korea Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.5 Southeat Asia Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
    7.1 Germany Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.2 UK Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.3 France Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.4 Russia Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.5 Italy Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
    8.1 Saudi Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.2 UAE Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.3 Egypt Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.4 Nigeria Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.5 South Africa Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
    9.1 Brazil Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.2 Argentina Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.3 Colombia Subcutaneous Injector Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Subcutaneous Injector Average Price Trend
    10.1 Market Price for Each Type of Subcutaneous Injector in North America (2016-2027)
    10.2 Market Price for Each Type of Subcutaneous Injector in Asia (2016-2027)
    10.3 Market Price for Each Type of Subcutaneous Injector in Europe (2016-2027)
    10.4 Market Price for Each Type of Subcutaneous Injector in Middle East & Africa (2016-2027)
    10.5 Market Price for Each Type of Subcutaneous Injector in South America (2016-2027)

11 Value Chain (Impact of COVID-19)
    11.1 Subcutaneous Injector Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Subcutaneous Injector Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Subcutaneous Injector Competitive Analysis
     12.1 Antares Pharma
        12.1.1 Antares Pharma Company Profiles
        12.1.2 Antares Pharma Product Introduction
        12.1.3 Antares Pharma Subcutaneous Injector Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Endo International
        12.2.1 Endo International Company Profiles
        12.2.2 Endo International Product Introduction
        12.2.3 Endo International Subcutaneous Injector Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 PharmaJet
        12.3.1 PharmaJet Company Profiles
        12.3.2 PharmaJet Product Introduction
        12.3.3 PharmaJet Subcutaneous Injector Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Bioject Medical Technologies Inc
        12.4.1 Bioject Medical Technologies Inc Company Profiles
        12.4.2 Bioject Medical Technologies Inc Product Introduction
        12.4.3 Bioject Medical Technologies Inc Subcutaneous Injector Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
     12.5 PenJet Corporation
        12.5.1 Medical International Technology Company Profiles
        12.5.2 Medical International Technology Product Introduction
        12.5.3 Medical International Technology Subcutaneous Injector Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 National Medical Products
        12.6.1 National Medical Products Company Profiles
        12.6.2 National Medical Products Product Introduction
        12.6.3 National Medical Products Subcutaneous Injector Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Valeritas
        12.7.1 Valeritas Company Profiles
        12.7.2 Valeritas Product Introduction
        12.7.3 Valeritas Subcutaneous Injector Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 European Pharma Group
        12.8.1 European Pharma Group Company Profiles
        12.8.2 European Pharma Group Product Introduction
        12.8.3 European Pharma Group Subcutaneous Injector Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
     12.9 PenJet Corporation
        12.9.1 PenJet Corporation Company Profiles
        12.9.2 PenJet Corporation Product Introduction
        12.9.3 PenJet Corporation Subcutaneous Injector Production, Revenue (2015-2020)
        12.9.4 SWOT Analysis
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
    Figure Global Subcutaneous Injector Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2016-2027)
    Table Regional Market Share in Terms of Production (2020-2027)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2020-2027)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure Global Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure Global Subcutaneous Injector Production Market Share (%) by Type (2019 -2020)
    Table Global Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure Global Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Global Subcutaneous Injector Revenue Market Share (%) by Type (2019-2020)
    Figure North America Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure North America Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure North America Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure North America Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Asia Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure Asia Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure Asia Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure Asia Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Europe Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure Europe Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure Europe Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure Europe Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Middle East & Africa Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure Middle East & Africa Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure Middle East & Africa Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Figure South America Subcutaneous Injector Production (K Unit) by Type (2016-2027)
    Figure South America Subcutaneous Injector Production (K Unit) and Growth Rate (2016-2027)
    Figure South America Subcutaneous Injector Revenue (Million USD) by Type (2016-2027)
    Figure South America Subcutaneous Injector Revenue (Million USD) and Growth Rate (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure North America Subcutaneous Injector Consumption (K Unit) and Growth Rate (2016-2027)
    Figure North America Subcutaneous Injector Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure Asia Subcutaneous Injector Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Asia Subcutaneous Injector Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure Europe Subcutaneous Injector Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Europe Subcutaneous Injector Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Subcutaneous Injector Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Subcutaneous Injector Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Figure South America Subcutaneous Injector Consumption (K Unit) and Growth Rate (2016-2027)
    Figure South America Subcutaneous Injector Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Subcutaneous Injector Different Application Field Consumption (K Unit)
    Table US Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Subcutaneous Injector Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in China
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in EU
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in USA
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in Japan
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in India
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Subcutaneous Injector in South America
    Figure Value Chain Structure of Subcutaneous Injector
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Subcutaneous Injector
    Figure Cost Structure of Subcutaneous Injector in 2020
    Table Distributors/Traders List
    Table Antares Pharma Profiles
    Table Antares Pharma Subcutaneous Injector Product Introduction
    Figure Antares Pharma Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Antares Pharma SWOT Analysis
    Table Endo International Profiles
    Table Endo International Subcutaneous Injector Product Introduction
    Figure Endo International Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Endo International SWOT Analysis
    Table PharmaJet Profiles
    Table PharmaJet Subcutaneous Injector Product Introduction
    Figure PharmaJet Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure PharmaJet SWOT Analysis
    Table Bioject Medical Technologies Inc Profiles
    Table Bioject Medical Technologies Inc Subcutaneous Injector Product Introduction
    Figure Bioject Medical Technologies Inc Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Bioject Medical Technologies Inc SWOT Analysis
    Table Medical International Technology Profiles
    Table Medical International Technology Subcutaneous Injector Product Introduction
    Figure Medical International Technology Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Medical International Technology SWOT Analysis
    Table National Medical Products Profiles
    Table National Medical Products Subcutaneous Injector Product Introduction
    Figure National Medical Products Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure National Medical Products SWOT Analysis
    Table Valeritas Profiles
    Table Valeritas Subcutaneous Injector Product Introduction
    Figure Valeritas Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Valeritas SWOT Analysis
    Table European Pharma Group Profiles
    Table European Pharma Group Subcutaneous Injector Product Introduction
    Figure European Pharma Group Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure European Pharma Group SWOT Analysis
    Table PenJet Corporation Profiles
    Table PenJet Corporation Subcutaneous Injector Product Introduction
    Figure PenJet Corporation Subcutaneous Injector Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Subcutaneous Injector Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Subcutaneous Injector Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Subcutaneous Injector Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports